Status:
UNKNOWN
Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation
Lead Sponsor:
Taichung Veterans General Hospital
Conditions:
Head and Neck Cancer
Mucositis
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
This study will enroll 60 consecutive patients who are scheduled to receive radiotherapy with/without chemotherapy due to head and neck cancers. Basic data will be recorded along with tumor related va...
Detailed Description
Chemotherapy and radiotherapy are important therapeutic modalities for head and neck cancer patients. Oral mucositis is a common comorbidity during chemotherapy and radiotherapy. It was reported that ...
Eligibility Criteria
Inclusion
- Head and neck cancer patients scheduled to receive radiotherapy with or without chemotherapy
Exclusion
- Prior radiotherapy to the head and neck region
- Severe liver or renal disease
- Reye's syndrome
- Allergy to glutamine
- Reluctant to join the study
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02282839
Start Date
January 1 2015
End Date
December 1 2017
Last Update
November 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Otolaryngology Head Neck Surgery, Taichung Veterans General Hospital
Taichung, Taiwan, Taiwan, 40705